Adipose-specific disruption of autotaxin enhances nutritional fattening and reduces plasma lysophosphatidic acid

被引:163
作者
Dusaulcy, Rodolphe [1 ,2 ]
Rancoule, Chloe [1 ,2 ]
Gres, Sandra [1 ,2 ]
Wanecq, Estelle [1 ,2 ]
Colom, Andre [1 ,2 ]
Guigne, Charlotte [1 ,2 ]
van Meeteren, Laurens A. [3 ,4 ]
Moolenaar, Wouter H. [3 ,4 ]
Valet, Philippe [1 ,2 ]
Saulnier-Blache, Jean Sebastien [1 ,2 ]
机构
[1] Fac Med Toulouse, INSERM, U1048, F-31073 Toulouse 4, France
[2] Univ Toulouse, UPS, Inst Med Mol Rangueil, IFR150, Toulouse, France
[3] Netherlands Canc Inst, Div Cell Biol, Amsterdam, Netherlands
[4] Netherlands Canc Inst, Ctr Biomed Genet, Amsterdam, Netherlands
关键词
adipocyte; high-fat diet; obesity; LYSOPHOSPHOLIPASE-D ACTIVITY; ACTIVATED RECEPTOR-GAMMA; ADIPOCYTE DIFFERENTIATION; INSULIN-RESISTANCE; EXPRESSION; INVOLVEMENT; FAT; SECRETION; OBESITY; TISSUE;
D O I
10.1194/jlr.M014985
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
070307 [化学生物学]; 071010 [生物化学与分子生物学];
摘要
Autotaxin (ATX) is a secreted lysophospholipase D that generates the lipid mediator lysophosphatidic acid (LPA). ATX is secreted by adipose tissue and its expression is enhanced in obese/insulin-resistant individuals. Here, we analyzed the specific contribution of adipose-ATX to fat expansion associated with nutritional obesity and its consequences on plasma LPA levels. We established ATX(F/F)/aP2-Cre (FATX-KO) transgenic mice carrying a null ATX allele specifically in adipose tissue. FATX-KO mice and their control littermates were fed either a normal or a high-fat diet (HFD) (45% fat) for 13 weeks. FATX-KO mice showed a strong decrease (up to 90%) in ATX expression in white and brown adipose tissue, but not in other ATX-expressing organs. This was associated with a 38% reduction in plasma LPA levels. When fed an HFD, FATX-KO mice showed a higher fat mass and a higher adipocyte size than control mice although food intake was unchanged. This was associated with increased expression of peroxisome proliferator-activated receptor (PPAR)gamma 2 and of PPAR-sensitive genes (aP2, adiponectin, leptin, glut-1) in subcutaneous white adipose tissue, as well as in an increased tolerance to glucose. These results show that adipose-ATX is a negative regulator of fat mass expansion in response to an HFD and contributes to plasma LPA levels.-Dusaulcy, R., C. Rancoule, S. Gres, E. Wanecq, A. Colom, C. Guigne, L. A. van Meeteren, W. H. Moolenaar, P. e Valet, and J. S. Saulnier-Blache. Adipose-specific disruption of autotaxin enhances nutritional fattening and reduces plasma lysophosphatidic acid. J. Lipid Res. 2011. 52: 1247-1255.
引用
收藏
页码:1247 / 1255
页数:9
相关论文
共 22 条
[1]
Targeted expression of Cre recombinase to adipose tissue of transgenic mice directs adipose-specific excision of loxP-flanked gene segments [J].
Barlow, C ;
Schroeder, M ;
LekstromHimes, J ;
Kylefjord, H ;
Deng, CX ;
WynshawBoris, A ;
Spiegelman, BM ;
Xanthopoulos, KG .
NUCLEIC ACIDS RESEARCH, 1997, 25 (12) :2543-2545
[2]
Potential involvement of adipocyte insulin resistance in obesity-associated up-regulation of adipocyte lysophospholipase D/autotaxin expression [J].
Boucher, J ;
Quilliot, D ;
Pradères, JP ;
Simon, MF ;
Grés, S ;
Guigné, C ;
Prévot, D ;
Ferry, G ;
Boutin, JA ;
Carpéné, C ;
Valet, P ;
Saulnier-Blache, JS .
DIABETOLOGIA, 2005, 48 (03) :569-577
[3]
Autotaxin [J].
Boutin, Jean A. ;
Ferry, Gilles .
CELLULAR AND MOLECULAR LIFE SCIENCES, 2009, 66 (18) :3009-3021
[4]
Autotaxin is released from adipocytes, catalyzes lysophosphatidic acid synthesis, and activates preadipocyte proliferation -: Up-regulated expression with adipocyte differentiation and obesity [J].
Ferry, G ;
Tellier, E ;
Try, A ;
Grés, S ;
Naime, I ;
Simon, MF ;
Rodriguez, M ;
Boucher, J ;
Tack, I ;
Gesta, S ;
Chomarat, P ;
Dieu, M ;
Raes, M ;
Galizzi, JP ;
Valet, P ;
Boutin, JA ;
Saulnier-Blache, JS .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (20) :18162-18169
[5]
S32826, A Nanomolar Inhibitor of Autotaxin: Discovery, Synthesis and Applications as a Pharmacological Tool [J].
Ferry, Gilles ;
Moulharat, Natacha ;
Pradere, Jean-Philippe ;
Desos, Patrice ;
Try, Anne ;
Genton, Annie ;
Giganti, Adeline ;
Beucher-Gaudin, Monique ;
Lonchampt, Michel ;
Bertrand, Marc ;
Saulnier-Blache, Jean-Sebastien ;
Tucker, Gordon C. ;
Cordi, Alex ;
Boutin, Jean A. .
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2008, 327 (03) :809-819
[6]
ATX expression and LPA signalling are vital for the development of the nervous system [J].
Fotopoulou, Stella ;
Oikonomou, Nikos ;
Grigorieva, Elena ;
Nikitopoulou, Ioanna ;
Paparountas, Triantafillos ;
Thanassopoulou, Artemis ;
Zhao, Zhenwen ;
Xu, Yan ;
Kontoyiannis, Dimitris L. ;
Remboutsika, Eumorphia ;
Aidinis, Vassilis .
DEVELOPMENTAL BIOLOGY, 2010, 339 (02) :451-464
[7]
Gesta S, 2002, J LIPID RES, V43, P904
[8]
IDENTIFICATION OF A POTENT ADIPOCYTE-SPECIFIC ENHANCER - INVOLVEMENT OF AN NF-1-LIKE FACTOR [J].
GRAVES, RA ;
TONTONOZ, P ;
ROSS, SR ;
SPIEGELMAN, BM .
GENES & DEVELOPMENT, 1991, 5 (03) :428-437
[9]
Adipose-specific peroxisome proliferator-activated receptor γ knockout causes insulin resistance in fat and liver but not in muscle [J].
He, WM ;
Barak, Y ;
Hevener, A ;
Olson, P ;
Liao, D ;
Le, J ;
Nelson, M ;
Ong, E ;
Olefsky, JM ;
Evans, RM .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2003, 100 (26) :15712-15717
[10]
Induction of adiponectin, a fat-derived antidiabetic and antiatherogenic factor, by nuclear receptors [J].
Iwaki, M ;
Matsuda, M ;
Maeda, N ;
Funahashi, T ;
Matsuzawa, Y ;
Makishima, M ;
Shimomura, I .
DIABETES, 2003, 52 (07) :1655-1663